Improving MMR vaccination rates: herd immunity is a realistic goal
Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. R...
Gespeichert in:
Veröffentlicht in: | BMJ 2011-10, Vol.343 (oct04 2), p.d5703-d5703 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | d5703 |
---|---|
container_issue | oct04 2 |
container_start_page | d5703 |
container_title | BMJ |
container_volume | 343 |
creator | Cockman, Philippa Dawson, Luise Mathur, Rohini Hull, Sally |
description | Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital.Design Observational time series study.Setting London Borough of Tower Hamlets.Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years.Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach.Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011.Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage. |
doi_str_mv | 10.1136/bmj.d5703 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_896526037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1943928802</sourcerecordid><originalsourceid>FETCH-LOGICAL-b294t-d0b6d47c29d2d2407f90736055e718efdea7e9394648eeb017872ebc19eeca973</originalsourceid><addsrcrecordid>eNp1kMlOwzAQhi0Egqpw4AWQJZAQhxQviRduUKBQVrFdLSeZgksWsBMEb09KgQMSpznMp_-f-RBap2RAKRe7aTkd5IkkfAH1aCxUlCjOF1GP6ERHinK1gtZCmBJCGJdKi2QZrTCqJaWC9dDBafni6zdXPeKLixv8ZrPMVbZxdYW9bSDs4SfwOXZl2Vau-cAuYIs92MKFxmX4sbbFKlqa2CLA2vfso_vjo7vhSXR-NTod7p9HKdNxE-UkFXksM6ZzlrOYyIkmkguSJCCpgkkOVoLmOhaxAkgJlUoySDOqATKrJe-j7Xlud_BrC6ExpQsZFIWtoG6Dmf3GBOEzcvMPOa1bX3XHGapjrplSnYw-2plTma9D8DAxL96V1n8YSsxMrenUmi-1HbvxndimJeS_5I_IDojmQOcF3n_31j8bIblMzOXD0Bzeno2uxyNtxh2_NednHf_3fgKlio1b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1943928802</pqid></control><display><type>article</type><title>Improving MMR vaccination rates: herd immunity is a realistic goal</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Jstor Complete Legacy</source><creator>Cockman, Philippa ; Dawson, Luise ; Mathur, Rohini ; Hull, Sally</creator><creatorcontrib>Cockman, Philippa ; Dawson, Luise ; Mathur, Rohini ; Hull, Sally</creatorcontrib><description>Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital.Design Observational time series study.Setting London Borough of Tower Hamlets.Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years.Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach.Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011.Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.d5703</identifier><identifier>PMID: 21971162</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Age ; Autism ; Child, Preschool ; Children ; Children & youth ; Childrens health ; Community Networks ; Competition ; Demography ; Disease ; England ; Epidemics ; Ethnicity ; Feasibility studies ; Herd immunity ; Humans ; Immunity, Herd ; Immunization Programs - economics ; Immunization Programs - methods ; Infectious diseases ; Measles ; Measles - prevention & control ; Measles-Mumps-Rubella Vaccine - administration & dosage ; Measles-Mumps-Rubella Vaccine - immunology ; Medical Informatics ; Minority & ethnic groups ; Mumps ; Outbreaks ; Population ; Poverty Areas ; Primary Health Care ; Public health ; Quality control ; Quality improvement ; Regression analysis ; Rubella ; Trends ; Vaccination ; Vaccines</subject><ispartof>BMJ, 2011-10, Vol.343 (oct04 2), p.d5703-d5703</ispartof><rights>BMJ Publishing Group Ltd 2011</rights><rights>Copyright: 2011 © BMJ Publishing Group Ltd 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b294t-d0b6d47c29d2d2407f90736055e718efdea7e9394648eeb017872ebc19eeca973</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/343/bmj.d5703.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/343/bmj.d5703.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21971162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cockman, Philippa</creatorcontrib><creatorcontrib>Dawson, Luise</creatorcontrib><creatorcontrib>Mathur, Rohini</creatorcontrib><creatorcontrib>Hull, Sally</creatorcontrib><title>Improving MMR vaccination rates: herd immunity is a realistic goal</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital.Design Observational time series study.Setting London Borough of Tower Hamlets.Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years.Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach.Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011.Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage.</description><subject>Age</subject><subject>Autism</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Children & youth</subject><subject>Childrens health</subject><subject>Community Networks</subject><subject>Competition</subject><subject>Demography</subject><subject>Disease</subject><subject>England</subject><subject>Epidemics</subject><subject>Ethnicity</subject><subject>Feasibility studies</subject><subject>Herd immunity</subject><subject>Humans</subject><subject>Immunity, Herd</subject><subject>Immunization Programs - economics</subject><subject>Immunization Programs - methods</subject><subject>Infectious diseases</subject><subject>Measles</subject><subject>Measles - prevention & control</subject><subject>Measles-Mumps-Rubella Vaccine - administration & dosage</subject><subject>Measles-Mumps-Rubella Vaccine - immunology</subject><subject>Medical Informatics</subject><subject>Minority & ethnic groups</subject><subject>Mumps</subject><subject>Outbreaks</subject><subject>Population</subject><subject>Poverty Areas</subject><subject>Primary Health Care</subject><subject>Public health</subject><subject>Quality control</subject><subject>Quality improvement</subject><subject>Regression analysis</subject><subject>Rubella</subject><subject>Trends</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kMlOwzAQhi0Egqpw4AWQJZAQhxQviRduUKBQVrFdLSeZgksWsBMEb09KgQMSpznMp_-f-RBap2RAKRe7aTkd5IkkfAH1aCxUlCjOF1GP6ERHinK1gtZCmBJCGJdKi2QZrTCqJaWC9dDBafni6zdXPeKLixv8ZrPMVbZxdYW9bSDs4SfwOXZl2Vau-cAuYIs92MKFxmX4sbbFKlqa2CLA2vfso_vjo7vhSXR-NTod7p9HKdNxE-UkFXksM6ZzlrOYyIkmkguSJCCpgkkOVoLmOhaxAkgJlUoySDOqATKrJe-j7Xlud_BrC6ExpQsZFIWtoG6Dmf3GBOEzcvMPOa1bX3XHGapjrplSnYw-2plTma9D8DAxL96V1n8YSsxMrenUmi-1HbvxndimJeS_5I_IDojmQOcF3n_31j8bIblMzOXD0Bzeno2uxyNtxh2_NednHf_3fgKlio1b</recordid><startdate>20111004</startdate><enddate>20111004</enddate><creator>Cockman, Philippa</creator><creator>Dawson, Luise</creator><creator>Mathur, Rohini</creator><creator>Hull, Sally</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20111004</creationdate><title>Improving MMR vaccination rates: herd immunity is a realistic goal</title><author>Cockman, Philippa ; Dawson, Luise ; Mathur, Rohini ; Hull, Sally</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b294t-d0b6d47c29d2d2407f90736055e718efdea7e9394648eeb017872ebc19eeca973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age</topic><topic>Autism</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Children & youth</topic><topic>Childrens health</topic><topic>Community Networks</topic><topic>Competition</topic><topic>Demography</topic><topic>Disease</topic><topic>England</topic><topic>Epidemics</topic><topic>Ethnicity</topic><topic>Feasibility studies</topic><topic>Herd immunity</topic><topic>Humans</topic><topic>Immunity, Herd</topic><topic>Immunization Programs - economics</topic><topic>Immunization Programs - methods</topic><topic>Infectious diseases</topic><topic>Measles</topic><topic>Measles - prevention & control</topic><topic>Measles-Mumps-Rubella Vaccine - administration & dosage</topic><topic>Measles-Mumps-Rubella Vaccine - immunology</topic><topic>Medical Informatics</topic><topic>Minority & ethnic groups</topic><topic>Mumps</topic><topic>Outbreaks</topic><topic>Population</topic><topic>Poverty Areas</topic><topic>Primary Health Care</topic><topic>Public health</topic><topic>Quality control</topic><topic>Quality improvement</topic><topic>Regression analysis</topic><topic>Rubella</topic><topic>Trends</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cockman, Philippa</creatorcontrib><creatorcontrib>Dawson, Luise</creatorcontrib><creatorcontrib>Mathur, Rohini</creatorcontrib><creatorcontrib>Hull, Sally</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cockman, Philippa</au><au>Dawson, Luise</au><au>Mathur, Rohini</au><au>Hull, Sally</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improving MMR vaccination rates: herd immunity is a realistic goal</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2011-10-04</date><risdate>2011</risdate><volume>343</volume><issue>oct04 2</issue><spage>d5703</spage><epage>d5703</epage><pages>d5703-d5703</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital.Design Observational time series study.Setting London Borough of Tower Hamlets.Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years.Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach.Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011.Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>21971162</pmid><doi>10.1136/bmj.d5703</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ, 2011-10, Vol.343 (oct04 2), p.d5703-d5703 |
issn | 0959-8138 1468-5833 1756-1833 |
language | eng |
recordid | cdi_proquest_miscellaneous_896526037 |
source | MEDLINE; BMJ Journals - NESLi2; Jstor Complete Legacy |
subjects | Age Autism Child, Preschool Children Children & youth Childrens health Community Networks Competition Demography Disease England Epidemics Ethnicity Feasibility studies Herd immunity Humans Immunity, Herd Immunization Programs - economics Immunization Programs - methods Infectious diseases Measles Measles - prevention & control Measles-Mumps-Rubella Vaccine - administration & dosage Measles-Mumps-Rubella Vaccine - immunology Medical Informatics Minority & ethnic groups Mumps Outbreaks Population Poverty Areas Primary Health Care Public health Quality control Quality improvement Regression analysis Rubella Trends Vaccination Vaccines |
title | Improving MMR vaccination rates: herd immunity is a realistic goal |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A32%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improving%20MMR%20vaccination%20rates:%20herd%20immunity%20is%20a%20realistic%20goal&rft.jtitle=BMJ&rft.au=Cockman,%20Philippa&rft.date=2011-10-04&rft.volume=343&rft.issue=oct04%202&rft.spage=d5703&rft.epage=d5703&rft.pages=d5703-d5703&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.d5703&rft_dat=%3Cproquest_cross%3E1943928802%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1943928802&rft_id=info:pmid/21971162&rfr_iscdi=true |